TY - JOUR
T1 - Intense Pulse Light Therapy for Meibomian Gland Dysfunction
AU - Kudrna, Jeremy J.
AU - Nguyen, Clever
AU - Vora, Gargi K.
N1 - Funding Information:
Special thanks to Dr. Laura K. Green, M.D. (Krieger Eye Institute, Baltimore, MD); Dr. Melissa Iglesias, D.O. (Gardens Eye Institute, Palm Beach Gardens, FL); Dr. Keshini Chunilal Parbhu, M.D. (Remagin LLC, Windermere, FL); Dr. Parvathy Pillai, MD (Krieger Eye Institute, Baltimore, MD); and Dr. Sandy Zhang-Nunes, MD (USC Roski Eye Institute, Los Angeles, CA), for their insight into IPL utilization in their respective practices.
Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2022/12
Y1 - 2022/12
N2 - Purpose of Review: This article reviews the history, indications, therapeutic safety/efficacy, and suspected mechanisms of action of intense pulse light therapy (IPL) in treating meibomian gland dysfunction (MGD) and related conditions. Recent Findings: IPL has been used by dermatologists since the 1980s. Today, through reduction of meibum viscosity, photocoagulation, photobiomodulation, photorejuvenation, and antimicrobial effects, IPL is becoming more widely employed as a novel approach for MGD in ophthalmology. Recent literature supports IPL as a safe and effective approach to managing the symptoms and signs of MGD, though patient selection and treatment duration/protocol vary. Summary: MGD is a common ophthalmologic condition that significantly impacts a patient’s quality of life. Oftentimes, MGD can be managed with conventional treatments. In more refractory cases of MGD, IPL represents an innovative, in-office, procedural-based therapeutic approach with promising efficacy and safety.
AB - Purpose of Review: This article reviews the history, indications, therapeutic safety/efficacy, and suspected mechanisms of action of intense pulse light therapy (IPL) in treating meibomian gland dysfunction (MGD) and related conditions. Recent Findings: IPL has been used by dermatologists since the 1980s. Today, through reduction of meibum viscosity, photocoagulation, photobiomodulation, photorejuvenation, and antimicrobial effects, IPL is becoming more widely employed as a novel approach for MGD in ophthalmology. Recent literature supports IPL as a safe and effective approach to managing the symptoms and signs of MGD, though patient selection and treatment duration/protocol vary. Summary: MGD is a common ophthalmologic condition that significantly impacts a patient’s quality of life. Oftentimes, MGD can be managed with conventional treatments. In more refractory cases of MGD, IPL represents an innovative, in-office, procedural-based therapeutic approach with promising efficacy and safety.
UR - http://www.scopus.com/inward/record.url?scp=85141366172&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85141366172&partnerID=8YFLogxK
U2 - 10.1007/s40135-022-00297-1
DO - 10.1007/s40135-022-00297-1
M3 - Review article
AN - SCOPUS:85141366172
SN - 2167-4868
VL - 10
SP - 138
EP - 152
JO - Current Ophthalmology Reports
JF - Current Ophthalmology Reports
IS - 4
ER -